Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Simone123 

Medicinova Inc. diskutieren

Medicinova Inc.

WKN: A0LF3U / Symbol: MNOV / Name: MediciNova Inc / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

3,22 €
-0,16 %

Buy Medicinova Inc.

Einschätzung Buy
Rendite (%) -
Kursziel 8,57
Veränderung
Endet am 02.12.25

MediciNova, Inc. (NASDAQ: MNOV) is now covered by analysts at D. Boral Capital. They set a "buy" rating and a $9.00 price target on the stock.
Ratings data for MNOV provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 8,59
Veränderung
Endet am 21.02.26

MediciNova, Inc. (NASDAQ: MNOV) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Ratings data for MNOV provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 8,30
Veränderung
Endet am 14.03.26

MediciNova, Inc. (NASDAQ: MNOV) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Ratings data for MNOV provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 8,16
Veränderung
Endet am 09.04.26

MediciNova, Inc. (NASDAQ: MNOV) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Ratings data for MNOV provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 4,34
Veränderung
Endet am 16.06.26

MediciNova, Inc. (NASDAQ: MNOV) had its price target lowered by analysts at B. Riley from $6.00 to $5.00. They now have a "buy" rating on the stock.
Ratings data for MNOV provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 7,64
Veränderung
Endet am 24.07.26

MediciNova, Inc. (NASDAQ: MNOV) had its "buy" rating re-affirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Ratings data for MNOV provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 7,74
Veränderung
Endet am 27.08.26

MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Ratings data for MNOV provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 7,67
Veränderung
Endet am 22.09.26

MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Ratings data for MNOV provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 7,72
Veränderung
Endet am 08.12.26

MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Ratings data for MNOV provided by MarketBeat